Latest News & Features
Americas
Christopher Viehbacher was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 31 August 2018
Americas
Iana Dimkova was selected in the LSIPR 50 2018 publication for her influence on the life sciences industry. She featured in the investment section, as LSIPR reports. 30 August 2018
Americas
Life sciences company Emergent BioSolutions announced plans to acquire Adapt Pharma earlier this week, in what the company said was an effort to combat the public health threat from opioid overdose. 30 August 2018
Americas
The US Food and Drug Administration has warned 21 websites over the illegal marketing of misbranded versions of opioid medications. 30 August 2018
Americas
Morgan Lewis & Bockius has expanded its IP practice by adding a patent prosecution and litigation team of lawyers from McDermott Will & Emery. 29 August 2018
Big Pharma
UK-based Horizon Discovery has entered into a CRISPR collaboration with an unnamed big pharma company. 29 August 2018
Americas
Purdue Pharma has settled another patent dispute involving pain drug OxyContin (oxycodone), just weeks after a suit against generics company Amneal Pharmaceuticals came to an end. 29 August 2018
article
Jean-François Formela was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports. 29 August 2018
Big Pharma
Late last week, Chugai Pharmaceutical emerged victorious after the English High Court found that the Japan-based company doesn’t owe royalties under a patent licence with UCB. 28 August 2018
Americas
Generics maker Alvogen secured a patent win at a US court last week, despite the judge finding that the company had infringed patents covering an opioid treatment. 28 August 2018